← Leaderboards
Joseph Church
University Of Southern California
$167,820
Attributed
$167,820
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71K · FY2005–09$100K$75K$50K$25K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$167,820 · 2
By mechanism
M01$167,820 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Frank D. Gilliland$43,061,630
- Rob S McConnell$18,252,821
- Yves A Declerck$18,916,589
- Robert C Seeger$12,536,093
- Joseph Leo Wiemels$16,840,536
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAutoimmune DiseasesChickenpoxChildrenClinically RelevantComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantHerpesviridae VaccineHiv InfectionsHuman SubjectImmunologic Deficiency SyndromesInfusion ProceduresInstitutionIntravenous ImmunoglobulinsIn VivoPatient Oriented ResearchPreparationResearch PersonnelResourcesSerologic TestsSourceUnited States National Institutes Of HealthVaccine Evaluation
Grant awards (4)
IN VIVO ASSESSMENT OF CLINICALLY RELEVANT AUTOANTIBODIES IN IVIG PREPARATIONS$26,669
M01 · FY2009 · RR · contact PI
SAFETY AND IMMUNOGENICITY OF OKA/MERCK VARICELLA VIRUS VACCINE IN CHILDREN W/HIV$12,111
M01 · FY2006 · RR · contact PI
SAFETY AND IMMUNOGENICITY OF OKA/MERCK VARICELLA VIRUS VACCINE IN CHILDREN W/HIV$70,993
M01 · FY2005 · RR
SAFETY AND IMMUNOGENICITY OF OKA/MERCK VARICELLA VACCINE$58,047
M01 · FY2004 · RR